Holen Sie sich die Stockscreener-App
537.73
0.04%
-0.19
Handel nachbörslich:
537.73
Schlusskurs vom Vortag:
$537.92
Offen:
$529.99
24-Stunden-Volumen:
231.15K
Relative Volume:
0.63
Marktkapitalisierung:
$15.36B
Einnahmen:
$2.68B
Nettoeinkommen (Verlust:
$460.40M
KGV:
33.83
EPS:
15.8963
Netto-Cashflow:
$711.00M
1W Leistung:
-0.09%
1M Leistung:
+17.64%
6M Leistung:
-11.98%
1J Leistung:
+68.48%
1-Tages-Spanne:
$527.00
$540.86
1-Wochen-Bereich:
$521.46
$544.42
52-Wochen-Spanne:
$306.70
$628.92
Medpace Holdings Inc Stock (MEDP) Company Profile
Firmenname
Medpace Holdings Inc
Sektor
Branche
Telefon
(513) 579-9911
Adresse
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP vs TMO, DHR, IDXX, NTRA, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MEDP
Medpace Holdings Inc
|
537.73 | 15.36B | 2.68B | 460.40M | 711.00M | 15.90 |
TMO
Thermo Fisher Scientific Inc
|
532.48 | 201.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
203.83 | 145.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
567.44 | 45.44B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
271.39 | 38.64B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
131.46 | 38.44B | 7.23B | 1.41B | 1.09B | 4.979 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2026-03-03 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-02-18 | Hochstufung | TD Cowen | Sell → Hold |
| 2026-02-13 | Hochstufung | Jefferies | Hold → Buy |
| 2026-02-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-02 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-09-03 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-29 | Herabstufung | UBS | Neutral → Sell |
| 2025-07-23 | Herabstufung | TD Cowen | Hold → Sell |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-04-22 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-03-24 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-10-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-27 | Herabstufung | UBS | Buy → Neutral |
| 2024-09-25 | Herabstufung | Jefferies | Buy → Hold |
| 2024-08-01 | Eingeleitet | Truist | Hold |
| 2024-05-29 | Eingeleitet | TD Cowen | Buy |
| 2024-05-28 | Eingeleitet | Mizuho | Buy |
| 2024-04-23 | Hochstufung | Jefferies | Hold → Buy |
| 2024-03-18 | Eingeleitet | Deutsche Bank | Hold |
| 2024-02-15 | Hochstufung | UBS | Neutral → Buy |
| 2023-10-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-05-08 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-10-27 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-07 | Eingeleitet | UBS | Sell |
| 2022-05-24 | Eingeleitet | Guggenheim | Neutral |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-10-02 | Hochstufung | Truist | Hold → Buy |
| 2020-06-08 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2020-05-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-04-30 | Hochstufung | SunTrust | Sell → Hold |
| 2020-04-20 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-03-17 | Herabstufung | SunTrust | Hold → Sell |
| 2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
| 2018-10-31 | Hochstufung | SunTrust | Hold → Buy |
| 2018-09-17 | Eingeleitet | SunTrust | Hold |
| 2018-07-31 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-11-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2017-09-29 | Eingeleitet | Raymond James | Mkt Perform |
| 2017-07-10 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
Alle ansehen
Medpace Holdings Inc Aktie (MEDP) Neueste Nachrichten
Bronstein, Gewirtz & Grossman, LLC Is Investigating Medpace Holdi - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Medpace Backs Phase 2 Cancer Imaging Trial With [68Ga]BED003 - TipRanks
Investigation Alert: Long-Term Investors who hold shares - openPR.com
Why Medpace (MEDP) Dipped More Than Broader Market Today - Yahoo Finance
Medpace Holdings, Inc. (MEDP) Stock Analysis: Is the Current Valuation Justified Amidst Strong Revenue Growth? - DirectorsTalk Interviews
Medpace Holdings (MEDP) Rallies As A More Cautious Narrative Questions The Valuation - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-07-09 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Shareholders to Learn More About the Investigation | NDAQ:MEDP | Press Release - Stockhouse
Baird downgrades Medpace stock rating to neutral, raises target to $547 By Investing.com - Investing.com Nigeria
Baird Downgrades Medpace to Neutral From Outperform, Adjusts PT to $547 From $477 - marketscreener.com
Baird downgrades Medpace stock rating to neutral, raises target to $547 - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Medpace Holdings, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsMEDP - AOL.com
Medpace Holdings, Inc. (MEDP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
A Look at Medpace Holdings Inc (MEDP) After 3.4% Decline -- GF V - GuruFocus
Medpace Shares Fall After Jefferies Downgrade - marketscreener.com
2026-07-07 | Medpace Holdings, Inc. (MEDP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NDAQ:MEDP | Press Release - Stockhouse
Medpace Growth Trends Show How CRO Demand Is Shifting in 2026 - The Globe and Mail
Jefferies Downgrades Medpace Holdings to Hold From Buy, Adjusts Price Target to $515 From $490 - marketscreener.com
Jefferies downgrades Medpace stock rating on valuation concerns By Investing.com - Investing.com Australia
Analyst recommendations: Ferguson, Medpace, Biogen, Crowdstrike, Take-Two… - marketscreener.com
Jefferies downgrades Medpace stock rating on valuation concerns - Investing.com
Medpace: The Recovery Narrative Looks Premature (NASDAQ:MEDP) - Seeking Alpha
Medpace Stock Outlook Turns on Backlog Quality and Cancellations - The Globe and Mail
MEDPMedpace Holdings Inc Latest SEC Filings - Finviz
Bronstein, Gewirtz & Grossman, LLC Encourages Medpace Holdings, Inc. (MEDP) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Medpace Holdings, I - The National Law Review
Enterprise value to revenue forward of Medpace Holdings, Inc. – NASDAQ:MEDP - TradingView
Enterprise value to EBIT forward of Medpace Holdings, Inc. – SWB:01P - TradingView
Here's Why Medpace Holdings (NASDAQ:MEDP) Has Caught The Eye Of Investors - Moomoo
Medpace (NASDAQ: MEDP) director converts restricted stock units into common shares - Stock Titan
Medpace (MEDP) director Robert O. Kraft exercises 33 RSUs, holds 955 shares - Stock Titan
Medpace (MEDP) director converts 36 RSUs into common shares - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating Medpace Holdings, Inc. (MEDP) And Encourages Shareholders to Connect - ACCESS Newswire
Medpace (MEDP) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating Medpace Holdings, Inc. (MEDP) And Encourages Investors to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Medpace Holdings, Inc. (MEDP) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Price to book forward of Medpace Holdings, Inc. – NASDAQ:MEDP - TradingView
Price to sales forward of Medpace Holdings, Inc. – NASDAQ:MEDP - TradingView
Medpace Holdings Inc (MEDP) Valuation: PE, PB & Fair Value Analysis - TradingKey
Enterprise value to EBITDA forward of Medpace Holdings, Inc. – NASDAQ:MEDP - TradingView
Price to earnings forward of Medpace Holdings, Inc. – LSX:A2APTV - TradingView
Medpace Holdings, Inc. Actuals & Estimates (NASDAQ:MEDP) - TradingView
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Medpace (MEDP) Advances While Market Declines: Some Information for Investors - Yahoo Finance
2026-06-25 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Investors to Learn More About the Investigation | NDAQ:MEDP | Press Release - Stockhouse
MEDP Forecast — Price Target — Prediction for 2027 - TradingView
Medpace Holdings Jumps as Investors Appear to Lean on Strong Fundamentals and Possible Short Covering - Moomoo
Medpace Holdings jumps as investors appear to lean on strong fundamentals and possible short covering - Quiver Quantitative
Finanzdaten der Medpace Holdings Inc-Aktie (MEDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.61%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):